- Home
- LVO vs ALGS Comparison
LVO vs ALGS Comparison
Compare LVO & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVO | ALGS |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 34.6M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LVO | ALGS |
|---|---|---|
| Price | $2.53 | $5.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $9.75 | ★ $52.38 |
| AVG Volume (30 Days) | ★ 87.5K | 37.9K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 78.57 | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,144,000.00 | $2,186,000.00 |
| Revenue This Year | $6.07 | $1,562.10 |
| Revenue Next Year | $27.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.24 | $3.98 |
| 52 Week High | $7.19 | $13.69 |
Technical Indicators
Market Signals| Indicator | LVO | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 43.73 |
| Support Level | $2.24 | $4.97 |
| Resistance Level | $5.83 | $6.91 |
| Average True Range (ATR) | 0.26 | 0.32 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 41.80 | 33.33 |
Price Performance
Historical ComparisonAbout LVO LiveOne Inc.
LiveOne Inc creator-first, music, entertainment and technology platform focused on delivering premium experiences and content world-wide through paid users and live and virtual events. It is in the acquisition, distribution and monetization of live music events, Internet radio, podcasting/vodcasting and music-related membership, streaming and video content. It provide services through a dedicated over-the-top application powered by Slacker (LiveOne App) called LiveOne. The company has three operating segments, PodcastOne, Slacker and Media Group. The company generates majority of revenue from PodcastOne. Its operations are based in the United States. It generate revenue through the sale of paid user services and advertising from its music offerings, from the licensing, advertising.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.